Trial Profile
Continuous ropivacaine infusion in treatment of postoperative pain in cardiac surgery.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2022
Price :
$35
*
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms NAROSYD
- 12 Oct 2022 Status changed from recruiting to completed.
- 19 Jul 2011 New trial record